{"nct_id":"NCT02531698","title":"A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years","status":"COMPLETED","status_verified_date":"2020-10","start_date":"2015-08","start_date_type":"ACTUAL","primary_completion_date":"2017-03","primary_completion_date_type":"ACTUAL","completion_date":"2017-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}